ORG 5667
Alternative Names: DGVAPLatest Information Update: 08 Jan 2001
Price :
$50 *
At a glance
- Originator Organon
- Class Coagulants; Neuroprotectants; Nootropics; Vasopressins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cognition disorders
Most Recent Events
- 08 Jan 2001 Discontinued-II for Cognition disorders (PO)